TH1001000221A - สิทธิบัตรยังไม่ประกาศโฆษณา - Google Patents
สิทธิบัตรยังไม่ประกาศโฆษณาInfo
- Publication number
- TH1001000221A TH1001000221A TH1001000221A TH1001000221A TH1001000221A TH 1001000221 A TH1001000221 A TH 1001000221A TH 1001000221 A TH1001000221 A TH 1001000221A TH 1001000221 A TH1001000221 A TH 1001000221A TH 1001000221 A TH1001000221 A TH 1001000221A
- Authority
- TH
- Thailand
- Prior art keywords
- announced
- advertised
- Prior art date
Links
Abstract
ยังไม่ประกาศโฆษณา
Claims (1)
- ยังไม่ประกาศโฆษณา
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009190145 | 2009-08-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH1001000221A true TH1001000221A (th) | |
| TH121482A TH121482A (th) | 2013-02-28 |
Family
ID=43607048
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TH1001000221A TH121482A (th) | 2009-08-19 | 2010-08-16 | องค์ประกอบทางเภสัชกรรมที่ประกอบด้วยอนุพันธ์ของควิโนลีน |
Country Status (33)
| Country | Link |
|---|---|
| US (3) | US20120077842A1 (th) |
| EP (1) | EP2468281B1 (th) |
| JP (1) | JP5048871B2 (th) |
| KR (1) | KR101496395B1 (th) |
| CN (1) | CN102470133B (th) |
| AU (1) | AU2010285740C1 (th) |
| BR (1) | BR112012003592B8 (th) |
| CA (1) | CA2771403C (th) |
| CL (1) | CL2012000412A1 (th) |
| CO (1) | CO6440512A2 (th) |
| CY (1) | CY1117481T1 (th) |
| DK (1) | DK2468281T3 (th) |
| ES (1) | ES2564797T3 (th) |
| HK (2) | HK1167607A1 (th) |
| HR (1) | HRP20160283T1 (th) |
| HU (1) | HUE026957T2 (th) |
| IL (1) | IL217197A (th) |
| MA (1) | MA33581B1 (th) |
| ME (1) | ME02359B (th) |
| MX (2) | MX2012002011A (th) |
| MY (1) | MY162940A (th) |
| NZ (1) | NZ598291A (th) |
| PE (1) | PE20121030A1 (th) |
| PL (1) | PL2468281T3 (th) |
| RS (1) | RS54686B1 (th) |
| RU (1) | RU2548673C3 (th) |
| SG (1) | SG178009A1 (th) |
| SI (1) | SI2468281T1 (th) |
| SM (1) | SMT201600077B (th) |
| TH (1) | TH121482A (th) |
| UA (1) | UA105671C2 (th) |
| WO (1) | WO2011021597A1 (th) |
| ZA (1) | ZA201108697B (th) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE428421T1 (de) | 2004-09-17 | 2009-05-15 | Eisai R&D Man Co Ltd | Medizinische zusammensetzung mit verbesserter stabilität und reduzierten gelierungseigenschaften |
| EP1925676A4 (en) | 2005-08-02 | 2010-11-10 | Eisai R&D Man Co Ltd | TEST METHOD FOR THE EFFECT OF A VASCULARIZATION INHIBITOR |
| EP1938842A4 (en) * | 2005-09-01 | 2013-01-09 | Eisai R&D Man Co Ltd | METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION COMPRISING IMPROVED CRASHING CHARACTERISTICS |
| KR101353763B1 (ko) | 2005-11-07 | 2014-01-21 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 혈관 신생 저해 물질과 ｃ―ｋｉｔ 키나아제 저해 물질의병용 |
| CN104706637A (zh) * | 2006-05-18 | 2015-06-17 | 卫材R&D管理有限公司 | 针对甲状腺癌的抗肿瘤剂 |
| EP2065372B1 (en) | 2006-08-28 | 2012-11-28 | Eisai R&D Management Co., Ltd. | Antitumor agent for undifferentiated gastric cancer |
| AU2008211952B2 (en) | 2007-01-29 | 2012-07-19 | Eisai R & D Management Co., Ltd. | Composition for treatment of undifferentiated-type of gastric cancer |
| CA2704000C (en) * | 2007-11-09 | 2016-12-13 | Eisai R&D Management Co., Ltd. | Combination of anti-angiogenic substance and anti-tumor platinum complex |
| RU2560683C2 (ru) | 2010-06-25 | 2015-08-20 | Эйсай Ар Энд Ди Менеджмент Ко., Лтд. | Противоопухолевое средство, задействующее соединения с ингибирующим эффектом к киназам в комбинации |
| AU2012246490B2 (en) | 2011-04-18 | 2016-08-04 | Eisai R&D Management Co., Ltd. | Therapeutic agent for tumor |
| EP2714937B1 (en) | 2011-06-03 | 2018-11-14 | Eisai R&D Management Co., Ltd. | Biomarkers for predicting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds |
| AU2013364953A1 (en) | 2012-12-21 | 2015-04-30 | Eisai R&D Management Co., Ltd. | Amorphous form of quinoline derivative, and method for producing same |
| WO2014185540A1 (en) | 2013-05-14 | 2014-11-20 | Eisai R&D Management Co., Ltd. | Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds |
| EP3524595B1 (en) | 2014-08-28 | 2022-08-10 | Eisai R&D Management Co., Ltd. | High-purity quinoline derivative and method for manufacturing same |
| CN106139156B (zh) * | 2014-11-14 | 2019-01-29 | 江苏恒瑞医药股份有限公司 | 一种含有喹啉衍生物或其盐的药物组合物 |
| SI3263106T1 (sl) * | 2015-02-25 | 2024-02-29 | Eisai R&D Management Co., Ltd. | Postopek zatiranja grenkobe derivata kinolina |
| CA2978226A1 (en) | 2015-03-04 | 2016-09-09 | Merck Sharpe & Dohme Corp. | Combination of a pd-1 antagonist and a vegfr/fgfr/ret tyrosine kinase inhibitor for treating cancer |
| CN106075456A (zh) * | 2015-04-27 | 2016-11-09 | 南京圣和药业股份有限公司 | 一种含乐伐替尼的药物组合物及其应用 |
| WO2016184436A1 (zh) * | 2015-05-21 | 2016-11-24 | 苏州晶云药物科技有限公司 | 乐伐替尼甲磺酸盐的新晶型及其制备方法 |
| KR102705821B1 (ko) | 2015-06-16 | 2024-09-12 | 가부시키가이샤 프리즘 바이오랩 | 항암제 |
| WO2017028660A1 (zh) * | 2015-08-17 | 2017-02-23 | 江苏恒瑞医药股份有限公司 | 一种含有喹啉衍生物或其盐的药物组合物 |
| RU2606592C1 (ru) * | 2015-10-07 | 2017-01-10 | Открытое Акционерное Общество "Татхимфармпрепараты" | Фармацевтическая композиция, содержащая кальциевую соль розувастатина (варианты) |
| CZ2016240A3 (cs) | 2016-04-27 | 2017-11-08 | Zentiva, K.S. | Soli lenvatinibu |
| EP3384901B1 (en) | 2017-04-04 | 2024-08-14 | Synthon B.V. | Pharmaceutical composition comprising lenvatinib mesylate |
| US10583133B2 (en) | 2018-03-12 | 2020-03-10 | Shilpa Medicare Limited | Pharmaceutical compositions of lenvatinib |
| CN110404079B (zh) * | 2018-04-27 | 2023-01-24 | 北京睿创康泰医药研究院有限公司 | 一种不含碳酸盐、低基因毒性杂质含量的喹啉衍生物或其盐的药物组合物 |
| US12102630B2 (en) | 2018-10-04 | 2024-10-01 | Synthon B.V. | Crystalline forms and processes of lenvatinib besylate |
| PT3632436T (pt) | 2018-10-04 | 2022-07-22 | Synthon Bv | Composição farmacêutica compreendendo sais de lenvatinib |
| CN113087666B (zh) * | 2020-01-09 | 2021-12-14 | 南京正大天晴制药有限公司 | 无定形喹啉甲酰胺衍生物的制备方法 |
| WO2021185006A1 (zh) * | 2020-03-18 | 2021-09-23 | 上海博志研新药物技术有限公司 | 一种仑伐替尼药物组合物、其制备方法及应用 |
| EP4147689A1 (en) | 2021-09-13 | 2023-03-15 | Lotus Pharmaceutical Co., Ltd. | Lenvatinib formulation |
| CN114306271B (zh) * | 2021-11-24 | 2023-04-07 | 石药集团中奇制药技术（石家庄）有限公司 | 一种仑伐替尼组合物 |
| CN115671074B (zh) * | 2022-11-15 | 2024-06-04 | 郑州德迈药业有限公司 | 一种甲磺酸仑伐替尼制剂及其制备方法 |
| EP4424303A1 (en) | 2023-02-28 | 2024-09-04 | Stada Arzneimittel Ag | Lenvatinib composition with improved bioavailability |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1458148A (en) * | 1974-04-19 | 1976-12-08 | Wyeth John & Brother Ltd | Carbocyclic-fused ring quinoline derivatives |
| US5009894A (en) * | 1988-03-07 | 1991-04-23 | Baker Cummins Pharmaceuticals, Inc. | Arrangement for and method of administering a pharmaceutical preparation |
| DE60134679D1 (de) | 2000-10-20 | 2008-08-14 | Eisai R&D Man Co Ltd | Stickstoff enthaltende aromatische Heterozyklen |
| JP4749660B2 (ja) * | 2002-10-16 | 2011-08-17 | 武田薬品工業株式会社 | 安定な固形製剤 |
| WO2004035052A1 (ja) * | 2002-10-16 | 2004-04-29 | Takeda Pharmaceutical Company Limited | 安定な固形製剤 |
| DE60305724T2 (de) * | 2002-10-21 | 2006-11-09 | Warner-Lambert Co. Llc | Tetrahydrochinolin-derivate als crth2 antagonisten |
| US7994159B2 (en) * | 2003-03-10 | 2011-08-09 | Eisai R&D Management Co., Ltd. | c-Kit kinase inhibitor |
| AU2004309217B2 (en) * | 2003-12-25 | 2008-11-06 | Eisai R&D Management Co., Ltd | Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)amino-phenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these |
| ATE428421T1 (de) * | 2004-09-17 | 2009-05-15 | Eisai R&D Man Co Ltd | Medizinische zusammensetzung mit verbesserter stabilität und reduzierten gelierungseigenschaften |
| US7550483B2 (en) * | 2005-06-23 | 2009-06-23 | Eisai R&D Management Co., Ltd. | Amorphous salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide and process for preparing the same |
| KR100951607B1 (ko) * | 2005-06-23 | 2010-04-09 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 4-(3-클로로-4-(시클로프로필아미노카르보닐)아미노페녹시)-7-메톡시-6-퀴놀린카르복사미드의 비정질 염 및 그 제조방법 |
| AR059066A1 (es) * | 2006-01-27 | 2008-03-12 | Amgen Inc | Combinaciones del inhibidor de la angiopoyetina -2 (ang2) y el inhibidor del factor de crecimiento endotelial vascular (vegf) |
| EP3028743A3 (en) * | 2008-03-05 | 2017-01-25 | Vicus Therapeutics, LLC | Compositions for mucositis and oncology therapies |
-
2010
- 2010-08-16 RU RU2012103471A patent/RU2548673C3/ru active Protection Beyond IP Right Term
- 2010-08-16 TH TH1001000221A patent/TH121482A/th unknown
- 2010-08-16 AU AU2010285740A patent/AU2010285740C1/en active Active
- 2010-08-16 HU HUE10809938A patent/HUE026957T2/en unknown
- 2010-08-16 NZ NZ598291A patent/NZ598291A/xx unknown
- 2010-08-16 ES ES10809938.3T patent/ES2564797T3/es active Active
- 2010-08-16 RS RS20160176A patent/RS54686B1/en unknown
- 2010-08-16 WO PCT/JP2010/063804 patent/WO2011021597A1/ja active Application Filing
- 2010-08-16 EP EP10809938.3A patent/EP2468281B1/en active Active
- 2010-08-16 MY MYPI2011700172A patent/MY162940A/en unknown
- 2010-08-16 ME MEP-2016-45A patent/ME02359B/me unknown
- 2010-08-16 SI SI201031141A patent/SI2468281T1/sl unknown
- 2010-08-16 CA CA2771403A patent/CA2771403C/en active Active
- 2010-08-16 MX MX2012002011A patent/MX2012002011A/es unknown
- 2010-08-16 DK DK10809938.3T patent/DK2468281T3/en active
- 2010-08-16 KR KR1020127003846A patent/KR101496395B1/ko active Protection Beyond IP Right Term
- 2010-08-16 PL PL10809938T patent/PL2468281T3/pl unknown
- 2010-08-16 UA UAA201203132A patent/UA105671C2/uk unknown
- 2010-08-16 PE PE2011002081A patent/PE20121030A1/es active IP Right Grant
- 2010-08-16 SG SG2011086022A patent/SG178009A1/en unknown
- 2010-08-16 CN CN2010800305086A patent/CN102470133B/zh not_active Ceased
- 2010-08-16 US US13/322,961 patent/US20120077842A1/en not_active Abandoned
- 2010-08-16 BR BR112012003592A patent/BR112012003592B8/pt active IP Right Grant
- 2010-08-16 JP JP2011527665A patent/JP5048871B2/ja active Active
- 2010-08-16 MX MX2014010594A patent/MX344927B/es unknown
-
2011
- 2011-11-25 ZA ZA2011/08697A patent/ZA201108697B/en unknown
- 2011-12-25 IL IL217197A patent/IL217197A/en active IP Right Grant
-
2012
- 2012-02-09 CO CO12022608A patent/CO6440512A2/es not_active Application Discontinuation
- 2012-02-16 CL CL2012000412A patent/CL2012000412A1/es unknown
- 2012-03-12 MA MA34683A patent/MA33581B1/fr unknown
- 2012-08-27 HK HK12108351.2A patent/HK1167607A1/xx not_active IP Right Cessation
- 2012-10-17 HK HK12110288.6A patent/HK1169599A1/zh unknown
-
2013
- 2013-06-21 US US13/923,858 patent/US20130296365A1/en not_active Abandoned
-
2016
- 2016-03-17 SM SM201600077T patent/SMT201600077B/xx unknown
- 2016-03-18 HR HRP20160283TT patent/HRP20160283T1/hr unknown
- 2016-04-05 CY CY20161100273T patent/CY1117481T1/el unknown
-
2021
- 2021-04-12 US US17/228,025 patent/US20210228722A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TH1001000221A (th) | สิทธิบัตรยังไม่ประกาศโฆษณา | |
| TH1001000193A (th) | สิทธิบัตรยังไม่ประกาศโฆษณา | |
| TH1001000154A (th) | สิทธิบัตรยังไม่ประกาศโฆษณา | |
| TH1001000151A (th) | สิทธิบัตรยังไม่ประกาศโฆษณา | |
| TH1001000149A (th) | สิทธิบัตรยังไม่ประกาศโฆษณา | |
| TH1001000044A (th) | สิทธิบัตรยังไม่ประกาศโฆษณา | |
| TH1201002026A (th) | สิทธิบัตรยังไม่ประกาศโฆษณา | |
| TH1201001575A (th) | สิทธิบัตรยังไม่ประกาศโฆษณา | |
| TH1001000043A (th) | สิทธิบัตรยังไม่ประกาศโฆษณา | |
| TH1001000142A (th) | สิทธิบัตรยังไม่ประกาศโฆษณา | |
| TH1201001468A (th) | สิทธิบัตรยังไม่ประกาศโฆษณา | |
| TH1003000791A (th) | สิทธิบัตรยังไม่ประกาศโฆษณา | |
| TH1003000254A (th) | สิทธิบัตรยังไม่ประกาศโฆษณา | |
| TH1001000141A (th) | สิทธิบัตรยังไม่ประกาศโฆษณา | |
| TH1002003198A (th) | สิทธิบัตรยังไม่ประกาศโฆษณา | |
| TH1002002736A (th) | สิทธิบัตรยังไม่ประกาศโฆษณา | |
| TH1001000140A (th) | สิทธิบัตรยังไม่ประกาศโฆษณา | |
| TH1002002532A (th) | สิทธิบัตรยังไม่ประกาศโฆษณา | |
| TH1002002325A (th) | สิทธิบัตรยังไม่ประกาศโฆษณา | |
| TH1001000139A (th) | สิทธิบัตรยังไม่ประกาศโฆษณา | |
| TH1001000127A (th) | สิทธิบัตรยังไม่ประกาศโฆษณา | |
| TH1002002123A (th) | สิทธิบัตรยังไม่ประกาศโฆษณา | |
| TH1002001368A (th) | สิทธิบัตรยังไม่ประกาศโฆษณา | |
| TH1001000125A (th) | สิทธิบัตรยังไม่ประกาศโฆษณา | |
| TH1001000123A (th) | สิทธิบัตรยังไม่ประกาศโฆษณา |